Prognosis of chronic immune thrombocytopenia in the setting of COVID-19 infection

Abstract

Background Although several studies discussed new-onset thrombocytopenia in the setting of COVID-19 infection, the course of chronic ITP in patients with COVID-19 and the propensity to relapse remains not well addressed. Methods This a retrospective study that included all adult patients with the diagnosis of chronic ITP who admitted to